The Institute of Cancer Research, London: New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse

'Ultra-sensitive' cancer blood test is highly accurate in identifying which breast cancer patients will relapse The 'Personalis NeXT Personal® liquid biopsy' test uses whole genome sequencing

Related Keywords

United Kingdom ,United States ,London ,City Of ,Chicago ,Illinois ,American ,Isaac Garcia Murillas ,Kristian Helin ,Barry Gusterson ,Nicholas Turner ,Richard Chen ,Andrew Tutt ,Simon Vincent ,Toby Robins ,Laura Milne ,Institute Of Cancer Research ,Personalis Inc ,Molecular Oncology Group ,American Society Of Clinical Oncology ,Breast Cancer Now Toby Robins Research Centre ,Cancer Research ,American Society ,Clinical Oncology ,Breast Cancer Now ,Staff Scientist ,Molecular Oncology ,Consultant Medical Oncologist ,Royal Marsden ,Chief Executive ,Chief Medical Officer ,Executive Vice President ,Professor Turner ,Professor Andrew ,Bill Freedman ,Professor Barry ,Ihr Portfolio ,